Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-33
Closed -$2.04K 796
2025
Q1
$2.04K Sell
33
-112
-77% -$7.42K ﹤0.01% 1396
2024
Q4
$10.5K Buy
145
+105
+263% +$8.2K ﹤0.01% 999
2024
Q3
$3.26K Sell
40
-68
-63% -$5.44K ﹤0.01% 1137
2024
Q2
$8.02K Sell
108
-2
-2% -$150 ﹤0.01% 931
2024
Q1
$8.58K Sell
110
-9
-8% -$670 ﹤0.01% 891
2023
Q4
$8.5K Buy
119
+24
+25% +$1.67K ﹤0.01% 862
2023
Q3
$6.59K Sell
95
-2
-2% -$151 ﹤0.01% 844
2023
Q2
$7.85K Buy
97
+79
+439% +$6.46K ﹤0.01% 800
2023
Q1
$1.45K Sell
18
-2
-10% -$161 ﹤0.01% 1126
2022
Q4
$1.5K Buy
20
+11
+122% +$783 ﹤0.01% 1139
2022
Q3
$1K Sell
9
-400
-98% -$27.7K ﹤0.01% 1207
2022
Q2
$28K Sell
409
-126
-24% -$9.35K 0.01% 462
2022
Q1
$41K Hold
535
0.01% 398
2021
Q4
$41K Sell
535
-31
-5% -$2.28K 0.01% 388
2021
Q3
$42K Sell
566
-120
-17% -$9K 0.01% 366
2021
Q2
$46K Sell
686
-31
-4% -$2.07K 0.01% 340
2021
Q1
$53K Buy
717
+692
+2,768% +$52.5K 0.01% 299
2020
Q4
$1K Buy
+25
New +$1.76K ﹤0.01% 679

Other funds holding HOLX

Hexagon Capital Partners's HOLX Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Hologic (HOLX) in Q2 2025, closing a stake of 33 shares — an estimated $2.04K sold.

Hexagon Capital Partners first reported a position in HOLX in Q4 2020 and held it in 18 quarters. The position peaked at $53K in Q1 2021. 693 funds tracked by Wall St. Rank hold HOLX as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Hologic position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 33 Hologic shares in Q2 2025, an estimated $2.04K.
  • Hexagon Capital Partners first reported a position in Hologic in Q4 2020 and held it in 18 quarters.
  • Hexagon Capital Partners's Hologic position peaked at $53K in Q1 2021.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.